West Pharmaceutical Services, Inc.

Good day and thank you for standing by. Welcome to the Q3 2026 West Pharmaceutical Services earnings conference call. At this time, all participants are in a listen-only mode. Please be advised that today's conference is being recorded. After the speaker's presentation, there will be a question and answer session. To ask a question, please press star 1 1 on your telephone and wait for your name to be announced. To withdraw your question, please press star 1 1 again. I would now like to hand the conference over to your speaker today, Michele Polinsky, Vice President of Communications.

Good morning, and welcome to West's third quarter earnings conference call, which has been webcast live. With me today on the call are West's President and CEO, Michele Lagarde, and West's Senior Vice President and CFO, Bob McMahon. Earlier today, we issued our third quarter financial results, a copy of the press release along with today's slide presentation containing supplemental information for your reference has been posted in the investor section of the company's website at investor.westpharma.com. Later today, a replay of the webcast will also be available in the investor section of our website. Before we begin, we'd like to remind you that statements made by management during this call and in the accompanying presentation contain forward-looking statements within the meaning of U.S. federal securities law. Please refer to the accompanying safe harbor statement in today's presentation and press release, in addition to other disclosures made by the company, such as our 10-K and 10-Q, regarding the risks to which the company is subject. During the call, management will also report on certain non-GAAP financial measures, including organic net sales, adjusted operating profit, adjusted operating profit margin, free cash flow, and adjusted diluted earnings per share. The accompanying disclosure statement as well as reconciliations of these non-GAAP financial measures to the most comparable financial results prepared in conformity with U.S. GAAP are provided in this morning's press release and today's presentation materials. I'll now turn the call over to our CEO, Michele Lagarde. Michele?

Thank you, Michele, and good morning, everyone. Thanks for joining us today. We're very pleased to welcome you to our earnings call. and before getting into the details of our strong third quarter performance, I want to begin by saying what a privilege it is for me to now be part of Team West. Having joined West two months ago, my priority has been spending time with our global teams, visiting our sites around the world and meeting with our customers and investors. It's been incredibly rewarding to connect and learn from the company's stakeholder network and start to identify how we can build on our strengths and continue to evolve. These have been valuable conversations and I'd like to give a few examples. First was my visit to our Ashweiler manufacturing site in Germany. What was immediately apparent was a strong mission-driven culture and teamwork among the colleagues. Confronted with the need to increase output, the team focused on execution and unlocking new efficiencies. For instance, by integrating more automation onto the production floor. This effort is helping to expand capacity and support our global network optimization to improve the service levels for our customers. A great example of our opportunity to drive more impact from continuous improvement across our company. Second, my conversations with our customers. I've called on these same customers for the last decade, so it wasn't hard to get transparent feedback from them. And from all my conversations, a very clear pattern has emerged. West is firmly on the very short list of preferred partners. Our reputation, combined with our deep technical and regulatory expertise, forms an incredible foundation to build upon. And we're invited to establish closer relationships with our customers. By doing so, we will understand their current and future needs even better, so we can drive innovation adoption faster and, of course, keep earning their business every day by our high quality and delivery performance. A clear path to continue to strengthen our enviable leadership position. These two examples point to the opportunity at C4West to drive more impact from strengthening our continuous improvement efforts and continuing to develop more strategic customer relations which will provide us with superior insights and allow us to better anticipate their future needs. And they were super excited to start contributing to our company's strategy and performance, build further on 100 plus years of accumulated experience, and unlock even more impact from our talented team. And with that, enable our customers to improve the lives of many more patients in need. Now let me recap our quarterly performance. I'm pleased to report that we've had a great third quarter, exceeding our expectations for both revenues and earnings. Revenues of $874 million grew 12% organically, and adjusted EPS of $2.66 was up 36% compared to last year. Given this strong performance, we are again raising our top and bottom line full year expectations, which Bob will talk about in more detail. Let me now shift to how our segments performed in the quarter. Our proprietary product segment delivered 16.6% organic growth. The highlight was HVP components, which grew 20%, driven by both GOP1 and non-GOP1 components demand, and HVP upgrades. HVP devices grew 26% organically after adjusting for SmartDOS 3.5, led by Crystal Zenith and Atman Systems. While the West Vantage segment revenues declined 7% organically, the performance was slightly better than expected. As a reminder, the strategy of West Vantage is shifting the business to higher value-added parts of drug handling. And as a result, we're rolling off legacy programs as the new programs continue to ramp. This is a muted effect on segment growth this year and next. To conclude my remarks, I want to thank our team members for their efforts and amazing work. Our end markets remain strong, our position as a leader is firm, and we will continue to step up our performance to exceed our customers' expectations which in turn will deliver value to all the stakeholders of West. I now turn the call over to Bob to provide more details on our quarter performance and updated guidance. Bob?